A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of Intranasal Single Dose SB-705498 on the Response to Intranasal Capsaicin Challenge in Non-allergic Rhinitis Patients.

Trial Profile

A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of Intranasal Single Dose SB-705498 on the Response to Intranasal Capsaicin Challenge in Non-allergic Rhinitis Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs GSK 705498 (Primary)
  • Indications Rhinitis
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 05 Aug 2013 Results published in the British Journal of Clinical Pharmacology.
    • 28 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.
    • 26 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top